LemonTradesLilly stock price today
Eli Lilly’s stock price today, live: the after-hours quote, the chart, its earnings, its weight-loss drugs and the news moving it.
- After hours
- $1,308.31 +0.12% 4:59 PM ET
- Day’s range
- $1,275.10–$1,321.21
- 52-week range
- $806.02–$1,321.21
- Market value
- $1,232B
- P/E (12 months)
- 44
- Volume
- 2.7M
The chart fills in as the desk logs prices.
What’s moving Eli Lilly
The headlines from the last three days that the LemonTrades desk scored highest for LLY, with why each one matters.
No big Eli Lilly headlines in the last three days.
Eli Lilly stock chart
Loading the chart…
Daily closes, split-adjusted. Highest close: $1,308.90 on Oct 22, 2026, 0.0% from here.
LLY returns
| Period | LLY then | Return | $1,000 became |
|---|---|---|---|
| 1 weekOct 15, 2026 | $1,251.61 | +4.6% | $1,046 |
| 1 monthSep 22, 2026 | $1,170.14 | +11.9% | $1,119 |
| 6 monthsApr 23, 2026 | $917.65 | +42.6% | $1,426 |
| This yearDec 31, 2025 | $1,074.68 | +21.8% | $1,218 |
| 1 yearOct 22, 2025 | $812.43 | +61.1% | $1,611 |
| 3 yearsOct 20, 2023 | $584.64 | +123.9% | $2,239 |
| 5 yearsOct 22, 2021 | $243.75 | +437.0% | $5,370 |
| 10 yearsOct 21, 2016 | $78.25 | +1,572.7% | $16,727 |
| Since listingJun 1, 1972 | $4.05 | +32,243.3% | $323,433 |
Quarterly results
| Quarter to | Revenue | Net income | EPS |
|---|---|---|---|
| Jun 30, 2026filed Aug 5, 2026 | $22.97B | $7.10B | $7.94 |
| Mar 31, 2026filed Apr 30, 2026 | $19.80B | $7.40B | $8.26 |
| Dec 31, 2025filed Feb 12, 2026 | $19.29B | $6.64B | $7.39 |
| Sep 30, 2025filed Oct 30, 2025 | $17.60B | $5.58B | $6.21 |
| Jun 30, 2025filed Aug 7, 2025 | $15.56B | $5.66B | $6.29 |
| Mar 31, 2025filed May 1, 2025 | $12.73B | $2.76B | $3.06 |
From Eli Lilly’s 10-Q and 10-K filings (GAAP; EPS diluted). Earnings over the last four quarters: $29.80 a share.
About Eli Lilly
Eli Lilly makes Mounjaro and Zepbound, the best-selling drugs for diabetes and weight loss, and in 2026 won FDA approval for Foundayo (orforglipron), a once-a-day weight-loss pill. Their sales have made Lilly the world’s most valuable drugmaker, worth more than a trillion dollars.
What moves LLY stock
- Zepbound and Mounjaro sales each quarter, and supply.
- Foundayo’s launch and the race with Novo Nordisk’s Wegovy.
- Drug prices: government deals, Medicare coverage and US pricing policy.
- Trial results for its next medicines.
Where things stand (October 2026)
- Q2 2026 Zepbound sales were $4.93 billion, above the $4.73 billion expected.
- 2026 guidance: revenue of $85–87 billion and adjusted earnings of $35.50–$36.50 a share.
- Q3 2026 results are due on October 29, 2026; the shares hit a record ahead of them.
Sources: Lilly Q1 2026 results · Stocktwits: LLY hits a record
Questions
What is LLY stock’s price today?
$1,308.90 at the last trade, updated every minute above.
Does Eli Lilly pay a dividend?
Yes, quarterly, though the yield is small because the share price is so high.
Why is Lilly stock so expensive?
Investors expect weight-loss drug sales to keep growing fast for years; at over $1,000 a share, many buy fractional shares.
When does Lilly report earnings?
Usually late in the month after each quarter ends, before the US open. The next is October 29, 2026.
Follow Eli Lilly on LemonTrades: LLY headlines scored the minute they break, ⚡ alerts when it moves 1.5% in five minutes with the likely cause, a morning brief with the day’s levels, and Twan to ask why it moved. Try LemonTrades free for 3 days, no card needed.
Market news and analysis, not financial advice. AI can misread a headline, so check the source before acting on anything important. Prices and news may be delayed.